Treatment of Chronic Antibody Mediated Rejection With Intravenous Immunoglobulins and Rituximab: A Multicenter, Prospective, Randomized, Double Blind Clinical Trial
American Journal of Transplantation - United Kingdom
doi 10.1111/ajt.14520
Full Text
Open PDFAbstract
Available in full text
Date
October 24, 2017
Authors
Publisher
Wiley